Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Carlos Pérez-Ruixo, n/a
Associate Scientific Director Pharmacom
Janssen Cilag S.A, Spain
Poster(s):
107: Pharmacokinetic & Immunogenicity Results from the China Cohort of the MAJESTEC-1 Study of Teclistamab for Relapsed/refractory Multiple Myeloma
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
